166 related articles for article (PubMed ID: 19520295)
1. In vitro human leukocyte labeling with (64)Cu: an intraindividual comparison with (111)In-oxine and (18)F-FDG.
Bhargava KK; Gupta RK; Nichols KJ; Palestro CJ
Nucl Med Biol; 2009 Jul; 36(5):545-9. PubMed ID: 19520295
[TBL] [Abstract][Full Text] [Related]
2. PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection.
Rini JN; Bhargava KK; Tronco GG; Singer C; Caprioli R; Marwin SE; Richardson HL; Nichols KJ; Pugliese PV; Palestro CJ
Radiology; 2006 Mar; 238(3):978-87. PubMed ID: 16505395
[TBL] [Abstract][Full Text] [Related]
3. A kit formulation for the preparation of [
Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte colony-stimulating factor for fluorine-18-fluorodeoxyglucose labeling in human leukocytes.
Moon SH; Lee HY; Eo JS; Kim SG; Shim HK; Kwon HW; Kim C; Kim YI; Lee DS; Chung JK; Lee MC
Nucl Med Commun; 2011 Mar; 32(3):186-91. PubMed ID: 21178645
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects.
Forstrom LA; Dunn WL; Mullan BP; Hung JC; Lowe VJ; Thorson LM
Nucl Med Commun; 2002 Aug; 23(8):721-5. PubMed ID: 12124476
[TBL] [Abstract][Full Text] [Related]
7. Effect of acetaminophen on the leukocyte-labeling efficiency of indium oxine In 111.
Augustine SC; Schmelter RF; Nelson KL; Petersen RJ; Qualfe MA
Am J Hosp Pharm; 1983 Nov; 40(11):1965-7. PubMed ID: 6418003
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
[TBL] [Abstract][Full Text] [Related]
9. Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
Oh M; Tanaka T; Kobayashi M; Furukawa T; Mori T; Kudo T; Fujieda S; Fujibayashi Y
Nucl Med Biol; 2009 May; 36(4):419-26. PubMed ID: 19423010
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG labelling of human leukocytes.
Forstrom LA; Mullan BP; Hung JC; Lowe VJ; Thorson LM
Nucl Med Commun; 2000 Jul; 21(7):691-4. PubMed ID: 10994674
[TBL] [Abstract][Full Text] [Related]
11. A new technique for the radiolabelling of mixed leukocytes with zirconium-89 for inflammation imaging with positron emission tomography.
Fairclough M; Prenant C; Ellis B; Boutin H; McMahon A; Brown G; Locatelli P; Jones AK
J Labelled Comp Radiopharm; 2016 Jun; 59(7):270-6. PubMed ID: 27061114
[TBL] [Abstract][Full Text] [Related]
12. No difference in sensitivity for occult infection between tropolone- and oxine-labeled indium-111 leukocytes.
Datz FL; Bedont RA; Baker WJ; Alazraki NP; Taylor A
J Nucl Med; 1985 May; 26(5):469-73. PubMed ID: 3921672
[TBL] [Abstract][Full Text] [Related]
13. On-cartridge preparation and evaluation of
Socan A; Petrik M; Kolenc Peitl P; Krošelj M; Rangger C; Novy Z; Svajger U; Gmeiner T; Decristoforo C
Nucl Med Biol; 2019 Apr; 71():23-31. PubMed ID: 31128475
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three different methods for radiolabelling human activated T lymphocytes.
Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
[TBL] [Abstract][Full Text] [Related]
15. The effect of cyclosporine-A on labeling blood cells with radiopharmaceuticals.
Owunwanne A; Shihab-Eldeen A
Nucl Med Biol; 1996 Nov; 23(8):1019-21. PubMed ID: 9004292
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oxine and tropolone methods for labeling human platelets with indium-111.
Kotzé HF; Heyns AD; Lötter MG; Pieters H; Roodt JP; Sweetlove MA; Badenhorst PN
J Nucl Med; 1991 Jan; 32(1):62-6. PubMed ID: 1899112
[TBL] [Abstract][Full Text] [Related]
17. Comparison of several indium-111 ligands in labeling blood cells: effect of diethylpyrocarbonate and CO2.
Goedemans WT; de Jong MM
J Nucl Med; 1987 Jun; 28(6):1020-6. PubMed ID: 3108467
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Dence CS; Ponde DE; Welch MJ; Lewis JS
Nucl Med Biol; 2008 Aug; 35(6):713-20. PubMed ID: 18678357
[TBL] [Abstract][Full Text] [Related]
19. In vitro comparison of equine granulocytes labeled with 99mTc-hexamethylpropyleneamine oxime or 111In-oxine.
Daniel GB; Tucker RL; Buckman T; Daniel SL
Am J Vet Res; 1992 Jun; 53(6):871-6. PubMed ID: 1626776
[TBL] [Abstract][Full Text] [Related]
20. Comparison of FDG and FDG-labeled leukocytes PET/CT in diagnosis of infection.
Yilmaz S; Aliyev A; Ekmekcioglu O; Ozhan M; Uslu L; Vatankulu B; Sager S; Halaç M; Sönmezoğlu K
Nuklearmedizin; 2015; 54(6):262-71. PubMed ID: 26503832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]